Upcoming Events
November 2026
Health in a World of Crises and Impunity
Join the Singapore launch of the Johns Hopkins–Lancet Commission report featuring Prof. Paul B. Spiegel to transform humanitarian health policy and practice.
- Global Health
MSF Scientific Days – Asia 2026
MSF Scientific Days – Asia 2026 has evolved into a key regional platform for showcasing research, innovation, and field-based experiences across humanitarian and public health settings.
- Conference
- Global Health
Singapore Antimicrobial Resistance Research Symposium
Held annually in conjunction with World Antimicrobial Resistance Awareness Week, this symposium will bring together global and local experts who will share their experiences, insights, and strategies on cutting-edge research, clinical practice, and evidence-based policy to tackle one of the most urgent public health threats of our time.
- Global Health
January 2027
Futureproofing the Global Health Architecture: Opportunities for the Southeast Asian Region
Join the upcoming Global Health Thought Leadership Dialogue to explore how Southeast Asia can translate the Accra Reset recommendations into regional health security action.
- Public Health Thought Leadership Dialogue
Past Events
July 2023
Comparative effectiveness clinical trials in infectious diseases research – pitfalls and novel approaches
Comparative effectiveness trials compare different established standards of care, for example different antibiotic choices or durations. The non-inferiority trial design is commonly used in infectious diseases research, but there are several methodologic issues and potential pitfalls that need to be carefully thought about when conducting a non-inferiority trial. Novel approaches such as ordinal outcomes and the DOOR/RADAR design may be useful alternatives, but come with their own issues.
Staff Research Rounds – Prof Ashley Akbari & Dr Pete Arnold
You are cordially invited to the ON-SITE SSHSPH Staff Research Round. We look forward to your attendance and we hope for an interesting discussion.
Precision Public Health Asia 2023 Conference
The conference will explore current and future strategies related to precision public health, covering genomics, population health, digital health, big data and artificial intelligence – and how they can benefit public health in the developed and developing worlds.
Staff Research Rounds – Dr Teerawattananon & Dr Isaranuwatchai
There has been lots of debate regarding an optimum value of cost-effectiveness threshold around the world. Many governments, for examples, in the United Kingdom and Thailand receive challenges whether the current CET used are too low and that their CET should be increased. To our knowledge, Thailand is the only country which has explicit CET and has increased the CET during the past 15 years. Therefore, Thailand is in a unique position to help answer the question of what happened when CET was increased. The findings from this study can assist in the discussion of whether and how CET values should be increased. Health Intervention and Technology Assessment Program (HITAP) in collaboration with Saw Swee Hock School of Public Health, National University of Singapore and the Hitotsubashi Institute for Advanced Study in Japan, was commissioned by the National Drug Subcommittee to answer the question of “What are the Impacts of Increasing Cost-effectiveness Threshold?” to assist in the discussion of whether or not Thailand’s current CET should be increased. The study objectives were to explore the impact of increasing cost-effectiveness threshold (CET) on the submitted drug price (published in economic evaluation reports) and the decision to include high-cost drugs in the National List of Essential Medicine (NLEM) in Thailand. Retrospective secondary data analysis using data from published economic evaluation reports being reviewed by the National Drug Subcommittee in the past 13 years.
May 2023
Using quality improvement methods in a humanitarian setting; an example from NW Syria
Quality Assurance or Quality Improvement methods are commonly associated with improving health care in stable situations. It is becoming clear that many of our humanitarian efforts are not achieving the desired goals because of poor quality. In this presentation the example will be used of applying quality improvement methods for haemodialysis services in a conflict affected situation in NW Syria. The tragic earthquake in the region has slowed the final parts of the project, but the approach and methodologies will be discussed, as well as the anticipated outcomes.
Integrating patient values into clinical trial design to increase enrolment and impact
While clinical trials provide some of the most rigorous sources of evidence, they are often hampered by low enrolment, and low impact on clinical decisions in the real world. This talk will describe a series of research which utilizes patient oriented methods to improve the design of future clinical trials. The first study focuses on how clinical trial designs can be modified to increase enrolment by considering the values of the patients eligible for recruitment. The second example will describe how patient values can be integrated into a composite endpoint for a clinical trial. This enables optimal treatments to be determined from a clinical trial for patients with differing values.